ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 우르소데옥시콜산 시장 규모는 향후 수년간 급성장이 예상됩니다. 성장의 원동력이 되는 것은 생활 습관과 관련된 건강 문제의 부담 증가, 간 비호 약에 대한 의존 증가, 장기간 간 질환 치료에 대한 요구 증가, 담즙산 유도체에 초점을 맞춥니다. 향후 몇 년간의 주요 시장 동향으로서는 표적 약물전달법의 발전, UDCA와 다른 간 보호 물질과의 병용, 새로운 약제 제제 전략, 담즙산 아날로그의 개발, 간 재생을 목적으로 한 RNA 치료법 출현 등이 있습니다.
간질환의 유병률 증가는 향후 수년간 우르소데옥시콜산 시장의 확대를 견인할 것으로 예측됩니다. 장기간의 과도한 음주는 간에 큰 피해를 줄 수 있기 때문에 간 관련 질병 증가의 주요 요인 중 하나는 알코올 비용 증가입니다.우르소데옥시콜산은 담즙의 흐름을 촉진하고 독성 담즙산의 수준을 저하시킴으로써 간질환의 치료에 중요한 역할을 하고 있습니다. 2024년 4월, Office for Health Improvement and Disparities는 간 질환으로 인한 조기 사망자 수를 남성 6,664명, 여성 3,929명으로 보고했습니다.
우르소데옥시콜산(UDCA) 시장의 주요 기업들은 간질환, 특히 담즙 울체성 간장애의 치료를 개선하기 위해 담즙산 유도체와 같은 고급 치료법의 개발을 점점 더 추진하고 있습니다. 담즙산 유도체는 간 기능을 지원하고 다양한 간 질환을 관리하기 위해 고안된 담즙산의 화학적 변형 형태입니다. 2024년 11월, Nora Pharma Inc.는 원발성 담즙성 담관염(PBC)을 포함한 담즙 울체성 간 질환의 치료를 목적으로 한 Ursodiol(우르소데옥시콜산)의 제네릭 의약품을 발매했습니다. 특히 질병 경과의 초기에 투여함으로써 간장애의 진행을 억제하는데 사용됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 우르소데옥시콜산 시장 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 우르소데옥시콜산 시장 : 성장률 분석
세계의 우르소데옥시콜산 시장 실적 : 규모와 성장, 2019-2024년
세계의 우르소데옥시콜산 시장 예측 : 규모와 성장, 2024-2029년, 2034F
세계의 우르소데옥시콜산 시장 : 총 시장 규모(TAM)
제6장 시장 세분화
세계의 우르소데옥시콜산 시장 : 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
합성 우르소데옥시콜산
추출 우르소데옥시콜산
세계의 우르소데옥시콜산 시장 : 투여 경로별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
경구
정맥내
피하
세계의 우르소데옥시콜산 시장 : 용도별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
담석
원발성 담즙성 담관염
원발성 경화성 담관염
비알코올성 지방성 간질환
기타 간 및 담도 질환
세계의 우르소데옥시콜산 시장 : 유통 채널별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 우르소데옥시콜산 시장 : 최종 사용자별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
병원
전문 클리닉
연구기관
기타 최종 사용자
세계의 우르소데옥시콜산 시장 : 합성 우르소데옥시콜산 세분화 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
화학합성 우르소데옥시콜산
생합성 우르소데옥시콜산
효소 합성 우르소데옥시콜산
세계의 우르소데옥시콜산 시장 : 추출 우르소데옥시콜산 세분화 유형별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
동물 유래 우르소데옥시콜산
담즙 추출 우르소데옥시콜산
천연 유래 추출 우르소데옥시콜산
제7장 지역별/국가별 분석
세계의 우르소데옥시콜산 시장 : 지역별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
세계의 우르소데옥시콜산 시장 : 국가별 분석과 예측, 2019-2024년, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
우르소데옥시콜산 시장 : 경쟁 구도
우르소데옥시콜산 시장 : 기업 프로파일
Mankind Pharma Pvt. Ltd : 개요, 제품 및 서비스, 전략 및 재무 분석
Abbott Healthcare Pvt. Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Shandong Octagon Chemicals Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
JSC Grindeks : 개요, 제품 및 서비스, 전략 및 재무 분석
Arch Pharmalabs : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Ind Swift Laboratories Ltd.
Symbiotec Pharmalab
Suzhou Tianlu Bio-pharmaceutical Co. Ltd
Zeal MediPharma
Prodotti Chimici e Alimentari SPA
Mitsubishi Tanabe Pharma Corporation
ICE Pharma Inc
Xi'an Tian Guangyuan Biotech Co. Ltd
Aamorb Pharmaceuticals Inc.
Axplora Inc
Octavius Pharma Pvt. Ltd
Sichuan Elixir Pharmaceutical Co. Ltd
Signova Pharma Pvt. Ltd.
Sinoway Industrial Co. Ltd
Valence Labs Pvt. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
우르소데옥시콜산 시장(2029년) : 새로운 기회를 제공하는 국가
우르소데옥시콜산 시장(2029년) : 새로운 기회를 제공하는 부문
우르소데옥시콜산 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
JHS
영문 목차
영문목차
Ursodeoxycholic acid (UDCA) is a naturally occurring bile acid produced in small quantities by the human liver. It is utilized as a medication for dissolving specific types of gallstones and for treating various liver and gallbladder conditions. UDCA aids in dissolving cholesterol-based gallstones and enhances bile flow, thereby safeguarding liver cells from damage. It is widely regarded as a safe and effective treatment for managing cholestatic liver diseases.
There are two primary types of ursodeoxycholic acid: synthetic and extracted. Synthetic UDCA is a laboratory-produced form of the natural bile acid, designed to treat liver disorders and dissolve cholesterol gallstones by enhancing bile flow and minimizing liver cell damage. This formulation can be administered orally, via intravenous injection, or subcutaneously. It is mainly prescribed for conditions such as gallstones, primary biliary cholangitis, primary sclerosing cholangitis, and non-alcoholic fatty liver disease. Distribution channels include hospital pharmacies, retail outlets, and online platforms, serving end users such as hospitals, specialized clinics, research centers, and other institutions.
The ursodeoxycholic acid market research report is one of a series of new reports from The Business Research Company that provides ursodeoxycholic acid market statistics, including the ursodeoxycholic acid industry's global market size, regional shares, competitors with the ursodeoxycholic acid market share, detailed ursodeoxycholic acid market segments, market trends and opportunities, and any further data you may need to thrive in the ursodeoxycholic acid market. This ursodeoxycholic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The ursodeoxycholic acid market size has grown rapidly in recent years. It will grow from $0.86 billion in 2024 to $0.96 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The expansion during the historical period can be attributed to factors such as the rising incidence of gallstone disease, increased awareness regarding liver health, higher diagnosis rates of primary biliary cholangitis, a greater shift toward non-invasive liver testing, and the aging global population.
The ursodeoxycholic acid market size is expected to see rapid growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The projected growth will be driven by the rising burden of lifestyle-related health issues, growing reliance on hepatoprotective medications, increased need for long-term liver disease treatments, a robust pipeline of clinical trials focused on bile acid derivatives, and growing interest in less invasive surgical options. Key market trends in the coming years include advancements in targeted drug delivery methods, combining UDCA with other liver-protecting substances, new drug formulation strategies, development of bile acid analogs, and the emergence of RNA-based therapies aimed at liver regeneration.
The growing prevalence of liver diseases is anticipated to drive the expansion of the ursodeoxycholic acid market in the coming years. Liver diseases encompass various conditions that hinder the liver's normal function, such as infections, inflammation, fatty liver, cirrhosis, and liver cancer. One of the key contributors to this increase in liver-related conditions is the rising level of alcohol consumption, as prolonged excessive drinking can cause significant liver damage. Ursodeoxycholic acid plays a crucial role in treating liver diseases by enhancing bile flow and decreasing the levels of toxic bile acids, which makes it particularly effective in managing conditions like primary biliary cholangitis. It helps improve patient outcomes by slowing the progression of liver damage and aiding in the dissolution of cholesterol gallstones, thereby boosting the overall effectiveness of treatments. For example, in April 2024, the Office for Health Improvement and Disparities, a UK-based government department, reported 6,664 premature deaths from liver disease among males and 3,929 among females, reflecting a 22.8% increase for males and a 33.1% increase for females compared to previous years. This surge in liver disease cases is contributing to the growth of the ursodeoxycholic acid market.
Leading companies in the ursodeoxycholic acid (UDCA) market are increasingly developing advanced therapies, such as bile acid derivatives, to improve the treatment of liver diseases, particularly cholestatic liver disorders. Bile acid derivatives are chemically modified forms of bile acids designed to support liver function and manage various liver conditions. For instance, in November 2024, Nora Pharma Inc., a pharmaceutical company based in Canada, introduced a generic version of Ursodiol (ursodeoxycholic acid) aimed at treating cholestatic liver diseases, including primary biliary cholangitis (PBC). This medication is used to enhance liver function and decelerate liver damage progression, especially when administered early in the disease course. Additionally, it helps dissolve and prevent cholesterol gallstones by altering bile composition and reducing toxic bile acid levels.
In November 2022, Sunshine Biopharma Inc., a pharmaceutical company based in the United States, acquired Nora Pharma Inc. for an undisclosed sum. Through this acquisition, Sunshine Biopharma intends to diversify its revenue sources, strengthen its presence in the generic and biosimilar drug sectors, and make strides toward becoming a fully integrated pharmaceutical company. Nora Pharma Inc., headquartered in Canada, markets ursodeoxycholic acid under the brand name NRA-Ursodiol.
North America was the largest region in the ursodeoxycholic acid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ursodeoxycholic acid report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the ursodeoxycholic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ursodeoxycholic acid market consists of sales of ursodiol tablets, ursodeoxycholic acid capsules, suspensions, injectables, and combination drugs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ursodeoxycholic Acid Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on ursodeoxycholic acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for ursodeoxycholic acid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ursodeoxycholic acid market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Synthetic Ursodeoxycholic Acid; Extraction Ursodeoxycholic Acid
2) By Route Of Administration: Oral; Intravenous; Subcutaneous
3) By Application: Gallstones; Primary Biliary Cholangitis; Primary Sclerosing Cholangitis; Non-Alcoholic Fatty Liver Disease; Other Liver And Biliary Diseases
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
5) By End User: Hospitals; Specialty Clinics; Research Institutions; Other End Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Ursodeoxycholic Acid Market Characteristics
3. Ursodeoxycholic Acid Market Trends And Strategies
4. Ursodeoxycholic Acid Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Ursodeoxycholic Acid Growth Analysis And Strategic Analysis Framework
5.1. Global Ursodeoxycholic Acid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Ursodeoxycholic Acid Market Growth Rate Analysis
5.4. Global Ursodeoxycholic Acid Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Ursodeoxycholic Acid Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Ursodeoxycholic Acid Total Addressable Market (TAM)
6. Ursodeoxycholic Acid Market Segmentation
6.1. Global Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Synthetic Ursodeoxycholic Acid
Extraction Ursodeoxycholic Acid
6.2. Global Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Subcutaneous
6.3. Global Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gallstones
Primary Biliary Cholangitis
Primary Sclerosing Cholangitis
Non-Alcoholic Fatty Liver Disease
Other Liver And Biliary Diseases
6.4. Global Ursodeoxycholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
6.5. Global Ursodeoxycholic Acid Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Research Institutions
Other End Users
6.6. Global Ursodeoxycholic Acid Market, Sub-Segmentation Of Synthetic Ursodeoxycholic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chemically Synthesized Ursodeoxycholic Acid
Biosynthetic Ursodeoxycholic Acid
Enzymatically Synthesized Ursodeoxycholic Acid
6.7. Global Ursodeoxycholic Acid Market, Sub-Segmentation Of Extraction Ursodeoxycholic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Animal-Derived Ursodeoxycholic Acid
Bile Extracted Ursodeoxycholic Acid
Natural Source Extracted Ursodeoxycholic Acid
7. Ursodeoxycholic Acid Market Regional And Country Analysis
7.1. Global Ursodeoxycholic Acid Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Ursodeoxycholic Acid Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Ursodeoxycholic Acid Market
9.1. China Ursodeoxycholic Acid Market Overview
9.2. China Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Ursodeoxycholic Acid Market
10.1. India Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Ursodeoxycholic Acid Market
11.1. Japan Ursodeoxycholic Acid Market Overview
11.2. Japan Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Ursodeoxycholic Acid Market
12.1. Australia Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Ursodeoxycholic Acid Market
13.1. Indonesia Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Ursodeoxycholic Acid Market
14.1. South Korea Ursodeoxycholic Acid Market Overview
14.2. South Korea Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Ursodeoxycholic Acid Market
15.1. Western Europe Ursodeoxycholic Acid Market Overview
15.2. Western Europe Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Ursodeoxycholic Acid Market
16.1. UK Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Ursodeoxycholic Acid Market
17.1. Germany Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Ursodeoxycholic Acid Market
18.1. France Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Ursodeoxycholic Acid Market
19.1. Italy Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Ursodeoxycholic Acid Market
20.1. Spain Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Ursodeoxycholic Acid Market
21.1. Eastern Europe Ursodeoxycholic Acid Market Overview
21.2. Eastern Europe Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Ursodeoxycholic Acid Market
22.1. Russia Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Ursodeoxycholic Acid Market
23.1. North America Ursodeoxycholic Acid Market Overview
23.2. North America Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Ursodeoxycholic Acid Market
24.1. USA Ursodeoxycholic Acid Market Overview
24.2. USA Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Ursodeoxycholic Acid Market
25.1. Canada Ursodeoxycholic Acid Market Overview
25.2. Canada Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Ursodeoxycholic Acid Market
26.1. South America Ursodeoxycholic Acid Market Overview
26.2. South America Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Ursodeoxycholic Acid Market
27.1. Brazil Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Ursodeoxycholic Acid Market
28.1. Middle East Ursodeoxycholic Acid Market Overview
28.2. Middle East Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Ursodeoxycholic Acid Market
29.1. Africa Ursodeoxycholic Acid Market Overview
29.2. Africa Ursodeoxycholic Acid Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Ursodeoxycholic Acid Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Ursodeoxycholic Acid Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Ursodeoxycholic Acid Market Competitive Landscape And Company Profiles
